Gene product of BCR-ABL exerts a constitutive tyrosine kinase activity crucial for the function of several signaling pathways involved in various malignancies, including CML [12]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.